22.EVALUATING THE EFFECTIVENESS OF THE METHOD ONSET OF LABOR WITH PROPESS® IN PATIENTS WITH HIGH-RISK PREGNANCIES AT NGHE AN OBSTETRICS AND PEDIATRICS HOSPITAL IN 2024
Main Article Content
Abstract
Objective: The study aims to Evaluation of the efficacy of Propess® on the onset of labor in patients with high-risk pregnancies at Nghe An Hospital of Obstetrics and Pediatrics in 2023. Subjects and methods: An observational study among 75 pregnant women with high-risk pregnancies and termination of pregnancy at Nghe An Hospital of Obstetrics and Pediatrics from 01/01/2024 to 30/09/2024.
Results: The median age was 28.97 ± 4.79. The average Bishop score before KPCD is 2.37 ± 1.48. The failure rate when KPCD equals Propess® is 2.67%. The success rates of levels 1, 2 and 3 were 97.33%, 96% and 89.33%, respectively. There were 89.33% of successful vaginal deliveries and 10.67% of cases requiring cesarean section. In 48% of cases, oxytocin infusion is required after KPCD with Propess.
Conclusion: There were 89.33% of successful vaginal deliveries and 10.67% of cases requiring cesarean section.
Article Details
Keywords
high-risk pregnancy, vaginal delivery, cesarean section
References
[2] Bộ Y tế (Ban hành kèm theo quyết định 4128/QĐ - BYT ngày 29/7/2016). Hướng Dẫn Quốc Gia về Các Dịch vụ Chăm Sóc Sức Khỏe Sinh Sản.; 2017.
[3] Tsakiridis I, Mamopoulos A, Athanasiadis A, Dagklis T. Induction of Labor: An Overview of Guidelines. Obstet Gynecol Surv. 2020;75(1):61-72. doi:10.1097/OGX.0000000000000752.
[4] ACOG Practice Bulletin No. 107: Induction of labor. Obstet Gynecol. 2009;114(2 Pt 1):386-397. doi:10.1097/AOG.0b013e3181b48ef5.
[5] Bộ Y tế (Ban hành kèm theo quyết định 1377/QĐ - BYT ngày 24 tháng 4 năm 2013). Gây chuyển dạ bằng thuốc. In: Quy Trình Kỹ Thuật Khám Bệnh, Chữa Bệnh Chuyên Ngành Phụ Sản.
[6] Dekker Rebecca L. “Labour induction for late-term or post-term pregnancy”. Women and Birth, 2016, 29(4), 394-398.
[7] Krithika KS, Aggarwal N, Suri V. Prospective randomised controlled trial to compare safety and efficacy of intravaginal Misoprostol with intracervical Cerviprime for induction of labour with unfavourable cervix. J Obstet Gynaecol J Inst Obstet Gynaecol. 2008;28(3):294-297. doi:10.1080/0144-3610802054972.